# Seizure Prevention in Traumatic Brain Injury With Levetiracetam and Lacosamide

> **NCT06866691** · PHASE4 · RECRUITING · sponsor: **Wake Forest University Health Sciences** · enrollment: 600 (estimated)

## Conditions studied

- Traumatic Brain Injury

## Interventions

- **DRUG:** levetiracetam
- **DRUG:** lacosamide

## Key facts

- **NCT ID:** NCT06866691
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-18
- **Primary completion:** 2027-04
- **Final completion:** 2027-04
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2026-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06866691

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06866691, "Seizure Prevention in Traumatic Brain Injury With Levetiracetam and Lacosamide". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT06866691. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*